炎症性肠病的管理:一种超越药物治疗的整体方法
Najwa F Mourad1, Jana G Hashash2, Viraj C Kariyawasam3
1Department of Nutrition and Food Sciences, Faculty of Agricultural and Food Sciences, American University of Beirut, Beirut, Lebanon.
Expert review of gastroenterology & hepatology
|May 19, 2025
概括
优化炎症性肠病 (IBD) 护理需要整合非药物战略,如心理社会支持,教育,饮食和运动. 这些方法提高了IBD患者的生活质量和治疗坚持.
科学领域:
- 胃肠病学 胃肠病学
- 内部医学 内部医学
- 患者护理 患者护理
背景情况:
- 炎症性肠病 (IBD) 管理传统上侧重于药物治疗.
- 非药物战略,包括心理社会支持,教育,体力活动和饮食,至关重要,但往往被忽视.
- 这些因素显著影响患者的生活质量 (QoL) 和治疗坚持.
研究的目的:
- 审查非药物干预措施在优化IBD护理中的作用和有效性.
- 强调患者与医生的沟通,教育,心理健康支持,运动和饮食的重要性.
- 评估这些策略的临床整合和证据.
主要方法:
- 关于研究IBD管理中的非药理学策略的文献综述.
- 分析患者与医生的沟通,教育,心理健康,运动和饮食的影响.
- 评估现有的有效性证据,并将其纳入常规护理.
主要成果:
- 一个强大的患者与医生的关系提高了信任和坚持.
- 患者教育赋予个人权力,导致更好的长期疾病控制.
- 心理社会支持对于应对焦虑,抑郁和疲劳至关重要.
- 身体活动和饮食干预措施有助于对抗肉类和营养不良,尽管缺乏指导方针.
结论:
- 整体的,多学科的护理整合非药物战略应该是IBD患者的标准.
- 常规护理应包括教育,心理健康查和结构化的饮食/运动计划.
- 医疗培训需要强调以患者为中心的沟通和战略.
- 未来的研究应侧重于基于证据的有效实施指南,以改善长期成果.
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
83
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
83
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
288
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
288
Inflammatory Bowel Disease V: Surgical Management
70
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
70
Irritable Bowel Syndrome III: Medical and Nursing Management
130
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
130
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
119
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
119
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
92
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
92


